To determine the effect of probiotics on the development of chemically induced (1, 2-dimethylhydrazine) colonic preneoplastic lesions, in mice.
Introduction
The incidence of cancer is increasing worldwide, and this trend is expected to continue. New cases of cancer are estimated This has led to interest in factors that can modulate the gut microbiota and, consequently, prevent the disease. Of special interest is the beneficial effect of certain probiotics, defined as live microorganisms that, when administered in adequate amounts confer health benefit to the host 3 . Some studies indicate that the ingestion of certain microorganisms reduces both the risk of developing certain types of cancer and tumor growth [4] [5] [6] [7] [8] . Attention has been focused on lactobacilli and bifidobacteria. However, it is still necessary to demonstrate the effectiveness of these and other species to suppress the development of preneoplastic lesions and to determine the ideal formulation of probiotics.
The aim of the present study was to determine the effect of Lactobacillus delbrueckii UFV-H2b20, Bifidobacterium animalis var. lactis Bb12 and Saccharomyces boulardii on the prevention of pre-neoplasic lesions in mouse colon. In addition, we aimed to determine whether the combined administration of L.
delbrueckii UFV-H2b20 and B. animalis var. lactis Bb12 would display a potential additive effect.
Methods
Eight week old male Swiss mice were distributed into five groups (n=10/group) as follows: .
On the fourteenth week of the experimental period, the mice were euthanized by cervical dislocation, under sedation, and the entire colon was collected for aberrant crypt analysis. The experimental design for this study is show in Figure 1A . Fresh cultures were prepared daily and the water changed every 24h when found to be about 10 8 c.f.u mL -1 .
Aberrant Crypt Foci analysis
At the end of the 14 week experiment, after euthanasia, the colons were immediately removed from the cecum down to the anus, rinsed in saline to remove the faeces, slit longitudinally and opened on paraffin plates with the mucosa facing up and fixed for 24 hours in 10% formaldehyde. Next, the sample was measured and divided in three equal fragments referred to as proximal, medial and distal in relation to the cecum, stained with 1% methylene blue for 2 minutes and rinsed with a phosphate buffer (PBS), in order to identify the foci of aberrant crypts. The foci throughout the entire mucosal surface of the large bowel were blindly counted by two independent and trained observers using a light microscope at 40x magnification according to the technique used by Bird 10 ( Figure 1B) . Because there was no significant difference between the evaluations of the two observers (p >0.05) (data not shown), the average of two counts was used for the analysis. The total number of aberrant crypt foci (ACF), its distribution along the colon and the multiplicity of the crypts were analyzed. The distribution among the proximal, middle and distal colon was evaluated, and multiplicity was determined by counting the foci containing three or fewer aberrant crypts and foci with more than three aberrant.
Statistical analysis
Data were analyzed using the SigmaPlot (Version 11.0).
Student's t-test was utilized to compare the counts of two observers and for further analysis of aberrant crypts between groups treated with probiotics and the Cont group. Analysis of ACF in the proximal, middle and distal regions of mouse colon was carried out using ANOVA followed by Holm-Sidak test. The differences were considered significant at p<0.05.
Results
There were no significant differences in the initial and after 14 weeks body weight and food intake among the experimental groups (data not shown).
All mice developed ACF in the colon ( Figure 1C) . Data on the total number of ACF, multiplicity of aberrant crypts and the distribution of ACF in the colon after 14 weeks of treatment in the different groups are summarized in Table 1 . The most potent protective effect against large ACF was observed in the Bif group, in which the number of foci with more than three aberrant crypts was decreased by 74% (0.6 ± 0. 
Discussion
In the present study, we demonstrate that consumption Previous studies also showed inhibition of preneoplastic lesions and tumors as a result of Lactobacillus plus Bifidobacterium supplementation (10 9 CFU/mL) [12] [13] [14] . In the current study, L.
delbrueckii UFV-H2B20 and B. animalis var. lactis Bb12 supplementation separately reduced the total number of ACF.
We also used a mixture containing 10 8 CFU/mL of each bacteria (L. delbrueckii UFV-H2B20 plus B. animalis var. lactis Bb12) to verify whether feeding mice a large amount of a combination of bacterial species would exert better effects than the use of a single species or the use of a small amount. However, we were not able to demonstrate the positive effects of such a combination. It was not possible to determine the reason why the combination of probiotics showed no positive result, but it's our impression that this may be due to the used dose that may have caused a derangement in the intestinal microbiota or in the immune system.
Aberrant crypt foci, that are enlarged and elevated relative to normal crypts, have also been detected in both rodents and humans and can be recognized as early neoplastic lesions.
Furthermore, crypt multiplicity (number of crypts per focus) has been considered to be one of the consistent predictors of tumor incidence. It has been suggested that large ACF are more predictive of tumor formation than small ACF 15 .
In the present study, we observed that small ACF were predominant in all groups. The formation of small ACF was mostly inhibited in the Lac group, while the most potent inhibition of large ACF was observed in the Bif group, when both were compared to the Cont group. However, the reduction seen in the Bif group was not significant, probably due to the high standard deviation.
In addition to crypt multiplicity, the location of ACF is also an interesting feature. In this study, the majority of ACF was present in the medial and distal colon in the Cont/DMH group.
According to the literature, in both human and animal colons, ACF are located in distal segments more often than in proximal regions, a characteristic also observed in colorectal cancers 16 . Interestingly, the reduction of ACF occurred in middle and distal regions in all groups treated with probiotics, except in Lac/Bif group that showed no significant positive effect.
To our knowledge, only one study has evaluated the effect of S. boulardii in cancer and analyzed its effect on tumor development. In this work, Chen et al. 17 More probiotic studies are needed to examine possible mechanisms for their potential benefit.
Conclusion
Among the three tested probiotics, only L. delbrueckii UFV-H2b20 and B. animalis var. lactis Bb12 administered alone protected against colon carcinogenesis.
